S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AYTU AYTU BioPharma Inc

1.5333

0.00 (0.00%)

Pre Market

Last Updated: 20:00:01

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

AYTU BioPharma (NASDAQ:AYTU)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more AYTU BioPharma Charts.

AYTU BioPharma (NASDAQ:AYTU)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more AYTU BioPharma Charts.

AYTU BioPharma Inc News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Saturday 12 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 3 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 1 October 2024 (3 months ago) • Edgar (US Regulatory)

More AYTU BioPharma Inc News Articles

Frank Temp ICAV Frank ST...

BNP Paribas Issuance

KEPLER WEBER ON

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions